Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
Dog (Canine) Monoclonal SRPK2 Primary Antibody for IF, WB - ABIN968376
Wang, Lin, Dyck, Yeakley, Songyang, Cantley, Fu: SRPK2: a differentially expressed SR protein-specific kinase involved in mediating the interaction and localization of pre-mRNA splicing factors in mammalian cells. in The Journal of cell biology 1998
SRPK2 may contribute to the formation of hyperphosphorylated tau and the pathogenesis of Alzheimer disease.
Interaction of Akt (show AKT1 Antibodies)-phosphorylated SRPK2 with 14-3-3 (show YWHAQ Antibodies) mediates cell cycle and cell death in neurons.
pausing of RNA polymerase II (RNA Pol II (show 0 Antibodies)) initiates a signaling cascade whereby the serine/arginine protein kinase 2 (show PKC Antibodies) (SRPK2) phosphorylates the DDX23 (show DDX23 Antibodies) helicase, culminating in the suppression of R-loops.
ten candidate variants were prioritised. Of these, SRPK2 (c.2044C>T[p.Arg682Trp]) and NOTCH1 (show NOTCH1 Antibodies) (c.3835C>T[p.Arg1279Cys]), co-segregated with disease in the family; however, previous functional analyses on SRPK2 make this an unlikely candidate. Functional analyses in the variant (c.3835C>T[p.Arg1279Cys]) of the known CHD (show CHDH Antibodies) gene NOTCH1 (show NOTCH1 Antibodies) demonstrated a non-significant decrease in signalling activity.
Delta-secretase phosphorylation by SRPK2 plays a critical role in aggravating Alzheimer disease pathogenesis.
In this study, it was found that the expression of SRPK2 was up-regulated in the clinical colon cancer samples. Overexpression of SRPK2 promoted the growth and migration of colon cancer cells, while knocking down the expression of SRPK2 inhibited the growth, migration and tumorigenecity of colon cancer cells.
Our results indicate that phosphorylation of SRPK2 plays a crucial role in the regulation of splicing process in head and neck squamous cell carcinoma (HNSCC), and that splicing kinases can be developed as a new class of therapeutic target in HNSCC.
Data indicate serine/arginine-rich protein (show MANF Antibodies) kinases SRPK1 (show SRPK1 Antibodies)/2/SRPIN340 complexes by molecular docking and molecular dynamics.
A conserved electronegative docking groove in SRPK2 is responsible for substrate binding.
the BLRF2 RS motif is phosphorylated by SRPK2 and is important for viral replication.
Our results demonstrate that SRPK1 (show SRPK1 Antibodies) and SRPK2 are host factors essential for Hepatitis C virus replication.
Short-term exercise resulted in a significant increase of mRNA expression of genes encoding proteins involved in the formation of precatalytic splisosome: SRPK2.
Serine/arginine-rich protein-specific kinase which specifically phosphorylates its substrates at serine residues located in regions rich in arginine/serine dipeptides, known as RS domains and is involved in the phosphorylation of SR splicing factors and the regulation of splicing. Promotes neuronal apoptosis by up-regulating cyclin-D1 (CCND1) expression. This is done by the phosphorylation of SRSF2, leading to the suppression of p53/TP53 phosphorylation thereby relieving the repressive effect of p53/TP53 on cyclin-D1 (CCND1) expression. Phosphorylates ACIN1, and redistributes it from the nuclear speckles to the nucleoplasm, resulting in cyclin A1 but not cyclin A2 up- regulation. Plays an essential role in splicesomal B complex formation via the phosphorylation of DDX23/PRP28.
SFRS protein kinase 2
, SFRS protein kinase 3
, serine/threonine-protein kinase SRPK2-like
, SR-protein-specific kinase 2
, SRSF protein kinase 2
, WW domain binding protein 6
, serine/arginine-rich protein-specific kinase 2
, serine/threonine-protein kinase SRPK2
, SR protein kinase 2
, serine kinase SRPK2
, serine/arginine-rich splicing factor kinase 2
, serine/arginine-rich protein specific kinase 2